Hoyer, Melissa J.
Capitanio, Cristina http://orcid.org/0000-0002-5297-9156
Smith, Ian R.
Paoli, Julia C. http://orcid.org/0000-0001-8266-1766
Bieber, Anna
Jiang, Yizhi
Paulo, Joao A. http://orcid.org/0000-0002-4291-413X
Gonzalez-Lozano, Miguel A. http://orcid.org/0000-0002-7837-151X
Baumeister, Wolfgang http://orcid.org/0000-0001-8154-8809
Wilfling, Florian http://orcid.org/0000-0002-6559-7261
Schulman, Brenda A. http://orcid.org/0000-0002-3083-1126
Harper, J. Wade http://orcid.org/0000-0002-6944-7236
Article History
Received: 24 April 2023
Accepted: 11 January 2024
First Online: 1 March 2024
Competing interests
: J.W.H. is a consultant and founder of Caraway Therapeutics (a wholly owned subsidiary of Merck & Co) and is a member of the scientific advisory board for Lyterian Therapeutics. B.A.S. is a co-founding scientific advisory board member of Interline Therapeutics and on the scientific advisory boards of Biotheryx and Proxygen. W.B. holds additional appointments as an honorary Professor at the Technical University Munich and a Distinguished Professor at ShanghaiTech University and is a member of the Life Science Advisory Board of Thermo Fisher Scientific. The other authors declare no competing interests.